Finance

Lists
Why is TTI down 6,73%?
Dive Deeper
TTI:CVE
Thiogenesis Therapeutics Corp
0,48 CA$
-6,73%
(-0,035) 1D
21 қаз., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for TTI...
Open
0,51 CA$
High
0,51 CA$
Low
0,48 CA$
Mkt. cap
33,94 млн
Avg. vol.
41,35 мың
Volume
27,00 мың
52-wk high
0,81 CA$
52-wk low
0,44 CA$
EPS
-0,12 CA$
Beta
0,44
Shares outstanding
69,98 млн
Open
0,51 CA$
High
0,51 CA$
Low
0,48 CA$
Mkt. cap
33,94 млн
Avg. vol.
41,35 мың
Volume
27,00 мың
52-wk high
0,81 CA$
52-wk low
0,44 CA$
EPS
-0,12 CA$
Beta
0,44
Shares outstanding
69,98 млн
News stories
From web sources and news partners
About Thiogenesis Therapeutics Corp
CEO-
Employees-
Founded2018
HeadquartersТоронто, Онтарио, Канада
Sector-
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,92 млн
1,27 млн
579,55 м.
1,24 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
471,84 м.
464,40 м.
338,28 м.
242,34 м.
Operating expense
2,39 млн
1,73 млн
917,82 м.
1,48 млн
Total operating expenses
2,39 млн
1,73 млн
917,82 м.
1,48 млн
Operating income
-2,39 млн
-1,73 млн
-917,82 м.
-1,48 млн
Other non operating income
-
-
-
-
EBT including unusual items
-2,38 млн
-1,73 млн
-911,82 м.
-1,49 млн
EBT excluding unusual items
-2,38 млн
-1,73 млн
-911,82 м.
-1,49 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,38 млн
-1,73 млн
-911,82 м.
-1,49 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
6,45 мың
4,42 мың
51,00
2,18 мың
Interest expense
-
-
-
-
Net interest expenses
6,45 мың
4,42 мың
51,00
2,18 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары